Market Overview:
Point-of-care diagnostics refers to a medical diagnostic testing process that takes place at or near the site of patient care, rather than in a centralized laboratory or hospital setting. These tests are designed to deliver rapid and reliable results that help healthcare providers make quick, informed decisions regarding patient diagnosis and treatment. The goal is to enable immediate decision-making without the need for a patient to wait for results or travel to another location for testing.
Point-of-care diagnostics is a rapidly advancing field that enables healthcare professionals and patients to perform diagnostic tests at or near the site of care. With growing adoption and innovations, point-of-care diagnostics is transforming healthcare delivery by making diagnostics faster, more accessible, and more efficient.
The market for point-of-care diagnostics is being driven by technological advancements, an aging population, rising incidences of chronic diseases, and the growing adoption of home-based testing. With rapid innovations in mobile health integration, artificial intelligence (AI), and digital diagnostics, the market is evolving to meet the needs of healthcare providers and patients for faster, more reliable diagnostics at the point of care.
Market Size & Growth Rate:
According to the DataM market research report, the global point-of-care diagnostics market size is valued at USD 15.46 billion in 2024, it is expected to reach USD 32.62 billion by 2033, with growth at a CAGR of 8.7% over the forecast period 2024-2033.
Global Point-of-Care Diagnostics Market Segmentation
By Product
- Infectious Disease Testing Products
- Blood Glucose Products
- Blood Gas & Electrolyte Products
- Hematology Testing Products
- Urinalysis Products
- Pregnancy and Fertility Testing Products
- Tumor/Cancer Profiling Products
- Drug-of-Abuse Products
- Others
By Technology
- Lateral Flow Assays
- Immunoassays
- Molecular Diagnostics
- Microfluidics
- Others
By Application
- Infectious Diseases
- Hematology
- Cardiology
- Endocrinology
- Oncology
- Drug Testing
- Neurology
- Others
By End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care Settings
- Ambulatory Surgery Centers (ASCs)
By Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Recent Developments in the Industry:
- In August 2024, HemoCue unveiled its revitalized brand. This rebranding represents a significant step in the company’s ongoing evolution, underscoring its dedication to addressing the evolving needs of the point-of-care diagnostics sector in a rapidly changing healthcare environment.
- In February 2024, HemoCue partnered with Novo Nordisk to enhance point-of-care diagnostic testing for children with type 1 diabetes in low- and middle-income countries. This collaboration aims to improve access to essential diagnostic tools and care for children living with type 1 diabetes in these regions.
Major Companies:
Major companies involved in the point-of-care diagnostics market include Abbott, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers AG, SEKISUI MEDICAL CO., LTD., BD, BioMérieux, QIAGEN, QuidelOrtho Corporation, and Trinity Biotech Plc, among others.
The Full Report has the following insights:
- The report offers a comprehensive evaluation of the market in terms of market value (US) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data (2018-2033), and verifiable projections about market size during the forecast period (2024-2033).
- Visualize the composition of the global point-of-care diagnostics market segmentation by product, technology, application, end-user, and region, highlighting the key commercial assets and players.
- Identify commercial opportunities in the global point-of-care diagnostics market by analyzing trends and co-development deals.
- The report also covers data insights on various industry forces such as Porter's five forces analysis, supply chain analysis, pricing analysis, and regulatory analysis.
- Excel data sheet with thousands of data points of the global point-of-care diagnostics market -level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in Excel for the key product of all major market players
- The report will provide access to approximately 61 market data tables, 64 figures, and close to 180 pages.